S&P Global upgrades Revvity outlook on leverage improvement By Investing.com
S&P Global Ratings changed Revvity Inc.’s (NYSE:RVTY) outlook to stable from negative while keeping its BBB issuer credit rating. It cited adjusted leverage held at or below 3x despite share repurchases, expecting leverage of 2.7x by end-2026 and 2.4x in 2027. It forecasts free operating cash flow above $500M and organic revenue growth of 3.5% to 4.5% in 2026-27.
How this was made
The 30-second read
Why it matters
Lower projected adjusted leverage (to 2.7x end-2026, 2.4x in 2027) and expected FCF above $500m support a more resilient capital-return profile and reduce credit-spread pressure.
Market read
For traders, the actionable element is the credit outlook shift plus quantified leverage, FCF, buyback, and margin trajectory that can re-rate RVTY’s risk premium.
What to watch
The China Immunodiagnostics divestiture is projected for 2028; execution timing and proceeds could affect how quickly margins improve.
Background
S&P Global Ratings maintained Revvity’s BBB issuer credit rating but changed the outlook to stable from negative, citing leverage discipline and buybacks.
Ticker impact
S&P Global Ratings revised Revvity’s outlook to stable from negative while affirming BBB and citing adjusted leverage held at or below 3x.
Moderately positive bias for RVTY as leverage and FCF outlook improve through 2026-2027.
The article provides specific rating outlook change plus quantified leverage, FCF, buyback, and margin improvement expectations, which can influence credit spreads and equity sentiment.
Market effects
Improving leverage and margin expectations for diagnostics/life-sciences can modestly support the group’s credit sentiment.
Primarily US credit and equity sentiment; limited direct regional spillover described.
Global diagnostics investors may view the stable outlook as a signal of improving balance-sheet discipline in the sector.
Counterpoint
A stable outlook is not an upgrade, and the article still hinges on forecasts (revenue growth, margins, FCF) that could miss.
Key entities
- companyRVTY
Revvity Inc., subject of the ratings outlook revision and leverage/FCF projections.
- ratings_agencyS&P Global Ratings
Revised Revvity’s outlook to stable from negative while affirming BBB.
